Health/Life Sciences2 min read
Araceli raises $4.5M for drug discovery tools aimed at reducing animal testing
Oregon-based Araceli Biosciences raised $4.5 million to commercialize cell-imaging tools that help researchers test potential drugs using human cells, with the aim of reducing reliance on animal studies while producing more relevant results. Read More
By Lisa StifflerGeekWire

Read the full story
Originally published by GeekWire on Nov 13, 2026.
Comments
Sign in to join the discussion.